Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
European Journal of Pharmacology
|
June 12, 2012
Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cells
Dove J Keith, Katherine Wolfrum, Amy J Eshleman, et al.
Bioorganic & Medicinal Chemistry
|
January 23, 2003
Syntheses of 3-carbomethoxy-4-(aryl)piperidines and in vitro and in vivo pharmacological evaluation: identification of inhibitors of the human dopamine transporter
Xianqi Feng, Keith Fandrick, Robert Johnson, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 12, 2003
Bivalent biogenic amine reuptake inhibitors
Keith Fandrick, Xianqi Feng, Aaron Janowsky, et al.
Life Sciences
|
October 17, 2003
"Broad spectrum" antidepressants: is more better for the treatment of depression?
Phil Skolnick, Piotr Popik, Aaron Janowsky, et al.
Journal of Neurochemistry
|
January 19, 2006
Hydrogen ion concentration differentiates effects of methamphetamine and dopamine on transporter-mediated efflux
Clare J Wilhelm, Robert A Johnson, Amy J Eshleman, et al.
Neurotoxicology and Teratology
|
February 19, 2017
The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity
Nicholas B Miner, James P O'Callaghan, Tamara J Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 28, 2016
Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine
Aaron Janowsky, Dilip K Tosh, Amy J Eshleman, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
November 12, 2017
Verification of a genetic locus for methamphetamine intake and the impact of morphine
Emily C Eastwood, Amy J Eshleman, Aaron Janowsky, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 9, 2011
Abuse liability profile of three substituted tryptamines
Michael B Gatch, Michael J Forster, Aaron Janowsky, et al.
European Journal of Pharmacology
|
February 15, 2003
Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor
Phil Skolnick, Piotr Popik, Aaron Janowsky, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
European Journal of Pharmacology
|
June 12, 2012
Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cells
Dove J Keith, Katherine Wolfrum, Amy J Eshleman, et al.
Bioorganic & Medicinal Chemistry
|
January 23, 2003
Syntheses of 3-carbomethoxy-4-(aryl)piperidines and in vitro and in vivo pharmacological evaluation: identification of inhibitors of the human dopamine transporter
Xianqi Feng, Keith Fandrick, Robert Johnson, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 12, 2003
Bivalent biogenic amine reuptake inhibitors
Keith Fandrick, Xianqi Feng, Aaron Janowsky, et al.
Life Sciences
|
October 17, 2003
"Broad spectrum" antidepressants: is more better for the treatment of depression?
Phil Skolnick, Piotr Popik, Aaron Janowsky, et al.
Journal of Neurochemistry
|
January 19, 2006
Hydrogen ion concentration differentiates effects of methamphetamine and dopamine on transporter-mediated efflux
Clare J Wilhelm, Robert A Johnson, Amy J Eshleman, et al.
Neurotoxicology and Teratology
|
February 19, 2017
The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity
Nicholas B Miner, James P O'Callaghan, Tamara J Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 28, 2016
Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine
Aaron Janowsky, Dilip K Tosh, Amy J Eshleman, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
November 12, 2017
Verification of a genetic locus for methamphetamine intake and the impact of morphine
Emily C Eastwood, Amy J Eshleman, Aaron Janowsky, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 9, 2011
Abuse liability profile of three substituted tryptamines
Michael B Gatch, Michael J Forster, Aaron Janowsky, et al.
European Journal of Pharmacology
|
February 15, 2003
Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor
Phil Skolnick, Piotr Popik, Aaron Janowsky, et al.
Page
of 7